Reig Jofre launches sleep supplement in France
Forté Pharma's new nutritional supplement combines natural extracts: valerian, passionflower, and vitamins B3 and B6, which contribute to prolong sleep for 8 hours.
Forté Pharma, Reig Jofre’s nutritional supplements line, has launched Forté Nuit 8h in France, its home market. The new nutritional supplement extends the company's health range and represents the natural alternative to help to fight sleep disorders.
Forté Nuit 8h improves the latency time; it also provides quality rest for 8 hours, without drowsiness or side effects upon awakening and without causing dependence.
Forté Nuit 8h acts with a double effect thanks to its natural formula, the optimal dose of its ingredients and its original bilayer tablets format, which provides an immediate effect through the rapid melatonin release that favors the first phase of the sleep cycle, as well as a long-acting effect thanks to the combination of natural extracts, valerian, passionflower, and vitamins B3 and B6, which contribute to prolong sleep for 8 hours.
Forté Pharma is planning Forté Nuit 8h’s international expansion and will start its marketing in Belgium during the first quarter of 2018.
Regarding the Spanish market, Forté Pharma plans to continue the development of the weight control segment during the first half of the year and to boost the rest of the categories in the second half.
Forte Pharma's portfolio is organized into four segments: energy (35% of its total sales), slimming (30%), health (22%) and beauty (13%) as at the end of September 2017.
At present, the marketing of Forte Pharma products is conducted mostly in Europe through its own sales network. Forte Pharma’s home market - France - is still the first market of the brand, which accounted for 67% of sales.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance